TDOC - Teladoc Health, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue417,907233,279123,15777,384
Cost of Revenue128,73561,62331,97121,041
Gross Profit289,172171,65691,18656,343
Operating Expenses
Research Development54,37334,45921,81514,210
Selling General and Administrative262,967176,913113,64889,273
Non Recurring----
Others----
Total Operating Expenses481,677292,090175,704129,387
Operating Income or Loss-63,770-58,811-52,547-52,003
Income from Continuing Operations
Total Other Income/Expenses Net-33,196-48,196-21,159-5,981
Earnings Before Interest and Taxes-63,770-58,811-52,547-52,003
Interest Expense-30,385-17,491-2,588-2,199
Income Before Tax-96,966-107,007-73,706-57,984
Income Tax Expense118-22551036
Minority Interest----
Net Income From Continuing Ops-97,084-106,782-74,216-58,020
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-97,084-106,782-74,216-58,020
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-97,084-106,782-74,216-58,020